UDP-3-O-((R)To analyze the native metal cofactor bound to LpxC, we developed a pulldown method to rapidly purify tagged LpxC under anaerobic conditions. The metal bound to LpxC purified from Escherichia coli grown in minimal medium is mainly Fe(II). However, the ratio of iron/ zinc bound to LpxC varies with the metal content of the medium. Furthermore, the iron/zinc ratio bound to native LpxC, determined by activity assays, has a similar dependence on the growth conditions. LpxC has significantly higher affinity for Zn(II) compared with Fe(II) with K D values of 60 ؎ 20 pM and 110 ؎ 40 nM, respectively. However, in vivo concentrations of readily exchangeable iron are significantly higher than zinc, suggesting that Fe(II) is the thermodynamically favored metal cofactor for LpxC under cellular conditions. These data indicate that LpxC expressed in E. coli grown in standard medium predominantly exists as the Fe(II)-enzyme. However, the metal cofactor in LpxC can switch between iron and zinc in response to perturbations in available metal ions. This alteration may be important for regulating the LpxC activity upon changes in environmental conditions and may be a general mechanism of regulating the activity of metalloenzymes.Gram-negative bacteria are important targets in the continuing fight against antibiotic-resistant infections. The development of new antibiotics to treat infections caused by resistant organisms is critically needed and will require novel targets. One potential source of targets in Gram-negative bacteria is the lipid A biosynthetic pathway (Fig. 1A) (1, 2), an essential building block of lipopolysaccharides (LPS) that make up the outer leaflet surrounding the cell wall in Gram-negative bacteria (2-4). In addition to being essential for cell viability, LPS are also referred to as endotoxins (2, 4, 5) and are responsible for immunogenic stimulation in septic shock that can lead to a number of deleterious effects, including severe hypotension, multiple organ dysfunction, and death (5). Consequently, inhibitors of lipid A biosynthesis have the potential to serve as both antibiotics and antiendotoxins (6). The UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) 3 catalyzes the committed and second overall step in lipid A biosynthesis, the hydrolysis of UDP-3-O-myristoyl-N-acetylglucosamine to UDP-3-O-myristoyl-glucosamine and acetate ( Fig. 1) (7-10). Consequently, inhibitors of LpxC are an active area of drug development (11)(12)(13)(14).LpxC was previously identified as a mononuclear Zn(II) metalloenzyme (Fig. 1B) (15) that also contains a weaker, inhibitory metal ion-binding site. This catalytic metal ion binds and polarizes an inner sphere water molecule that is activated by general base catalysis to serve as the nucleophile for hydrolysis of the acetyl substrate (Fig. 1C) (16, 17). However, recent evidence has shown that LpxC is more active with Fe(II) as its metal ion cofactor compared with Zn(II) (18). This increase in activity may correlate with a change in the ground stat...